Little-Known Facts About Sourcing from Emerging Markets Discover how strategic comparator sourcing can save over 50% in costs while maintaining regulatory compliance and quality standards.

INDUSTRY CHALLENGE The Comparator Sourcing Crisis Comparator sourcing has become an "Achilles Heel" in pharmaceutical product development. As competition to develop biosimilars has increased, so has demand for comparators. Clinical trials are frequently stuck, delayed, or abandoned due to non-availability of comparators4creating significant bottlenecks in the development process.

The Core Confusion

"Sourced" vs "Licensed" "Sourced" Manufactured or originates in SRA countries (US, EU, Australia, Japan, South Africa). The product maintains its quality, safety, and efficacy regardless of where it's sold. "Licensed" Approved for sale in pharmacies of a particular SRA country. Country-specific packaging with local language, PZN numbers, and regulatory warnings. Regulators require comparators "sourced" from SRA markets, but CROs often misinterpret this as "licensed"4driving unnecessary cost escalation.

Understanding Product Registration The CTD Dossier Process To sell products globally, manufacturers undergo product registration with National Health Authorities. The CTD (Common Technical Document) dossier includes five modules covering administrative, non-clinical, clinical, and CMC details. Certificate of Pharmaceutical Product (CPP) is mandatory4developed under WHO Certification scheme. It proves quality, safety, efficacy, and GMP compliance without requiring additional clinical validation or facility inspections.

Real-World Example

Rituximab EU Market: MabThera Manufactured by Roche Diagnostics in Germany. Price: ¬2,900 per 500mg vial. Indian Market: Ristova Same manufacturer, same quality. Price: ¬1,100 per 500mg vial4 62% cost savings. The product undergoes thorough CTD registration ensuring identical quality, safety, and efficacy. Manufacturers follow "One product, One Dossier worldwide" principle.

Key Advantages of RoW Market Sourcing

  1. Significant Price Savings Pharma majors use differential pricing strategies. With comparators constituting 30%+ of development costs, sourcing from RoW markets delivers substantial savings.
  2. Flexible Quantities Easily obtain quantities of 500s, 1000s, or more from RoW markets like India4far easier than controlled SRA supply chains.
  3. Batch Availability Multiple batches or single batches4whatever your requirement, RoW markets offer superior availability and faster access.

The Bottom Line Same Quality Products sourced from SRA but sold in RoW markets maintain identical QSE and GMP parameters through rigorous CTD registration. Lower Cost Save over 50% on comparator costs while maintaining full regulatory compliance and quality standards. Addressing Concerns Work with WHO cGSDP certified wholesalers like GNH India4certified by SGS France for GDP compliance4to ensure counterfeit protection and supply chain integrity.